Form 10-Q · Quarterly report
Corpay 10-Q, filed Aug 10, 2026
- Filed
- CIK
- 0001175454
- Accession no.
- 0001175454-26-000050
Summary
Corpay reported second-quarter 2026 revenues, net of $1.34 billion, up from $1.10 billion a year earlier, while net income attributable to Corpay fell to $248.3 million from $284.2 million and diluted earnings per share declined to $3.70 from $3.98. Corpay also refined its reportable segments in the first quarter of 2026 into Corporate Payments, Vehicle Payments, and Lodging Payments, recasting prior periods.
Key points
- Adjusted net income attributable to Corpay was $464.4 million, or $7.00 per diluted share, versus $366.4 million, or $5.13, for the same quarter a year earlier.
- Adjusted EBITDA was $767.2 million at a 57.3% margin, compared with $620.6 million at 56.3% a year earlier.
- Corporate Payments revenue rose to $548.7 million from $387.3 million and Vehicle Payments revenue rose to $580.2 million from $512.0 million year over year.
- Approximately 76% of Corpay's business is in the U.S., Brazil, and the U.K., and it provides payment solutions in more than 200 countries.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Overview Corpay is a global corporate payments and spend management company that helps businesses simplify, automate and control the way they make payments and optimize commercial payment workflows. Corpay provides a broad suite of payment and spend management solutions, including accounts payable automation and cross-border payment and foreign exchange risk management solutions (including foreign exchange spot, forward and option transactions), commercial card programs (e.g., purchasing cards, business cards and virtual cards), vehicle payment solutions (e.g., fuel cards, toll payments and related services) and lodging payment solutions (e.g.…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.